ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Cancer Prevention Fellowship Program

April 28, 2000

Multivitamin Use Doesn’t Impact Outcomes, Study Finds

September 24, 2010

Study Examines Lung Cancer Among Lifelong Nonsmokers

October 31, 2008

Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds

November 25, 2005

DCBD Board Approved Concepts For New Grants In Cytogenetics Solid Tumor Diagnoses

December 13, 1984

NIH Financial Plan Slated For Discussion At Dec. 18 Meeting

December 14, 1990